US Bancorp’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

US Bancorp’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-1,000	Closed	-$1K	–	3743
2016 Q2	$1K	Hold	1,000	–	–	﹤0.01%	3529
2016 Q1	$1K	Hold	1,000	–	–	﹤0.01%	3506
2015 Q4	$1K	Hold	1,000	–	–	﹤0.01%	3573
2015 Q3	$2K	Hold	1,000	–	–	﹤0.01%	3467
2015 Q2	$2K	Hold	1,000	–	–	﹤0.01%	3458
2015 Q1	$2K	Hold	1,000	–	–	﹤0.01%	3473
2014 Q4	$1K	Hold	1,000	–	–	﹤0.01%	3500
2014 Q3	$1K	Hold	1,000	–	–	﹤0.01%	3475
2014 Q2	$2K	Hold	1,000	–	–	﹤0.01%	3403
2014 Q1	$3K	Hold	1,000	–	–	﹤0.01%	3325
2013 Q4	$3K	Hold	1,000	–	–	﹤0.01%	3256
2013 Q3	$3K	Hold	1,000	–	–	﹤0.01%	3166
2013 Q2	$2K	Buy	+1,000	New	+$5.24K	﹤0.01%	3162

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

US Bancorp's ECTE Position: Q3 2016 in Review

US Bancorp sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 1,000 shares — an estimated $1K sold.

US Bancorp first reported a position in ECTE in Q2 2013 and held it in 13 quarters. The position peaked at $3K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

US Bancorp reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
US Bancorp sold 1,000 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016, an estimated $1K.
US Bancorp first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 13 quarters.
US Bancorp's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $3K in Q1 2014.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on US Bancorp's 13F filing for Q3 2016, filed 4 Nov 2016.